Lin Z, Yao Q, Lai K, Jiao K, Zeng X, Lei G
Genome Biol. 2024; 25(1):311.
PMID: 39696608
PMC: 11658101.
DOI: 10.1186/s13059-024-03455-9.
Whisnant A, Dyck Dionisi O, Salazar Sanchez V, Rappold J, Djakovic L, Grothey A
J Virol. 2024; 98(10):e0117824.
PMID: 39316591
PMC: 11494995.
DOI: 10.1128/jvi.01178-24.
Djakovic L, Hennig T, Reinisch K, Milic A, Whisnant A, Wolf K
Nat Commun. 2023; 14(1):4591.
PMID: 37524699
PMC: 10390501.
DOI: 10.1038/s41467-023-40217-w.
Hao M, Tang J, Ge S, Li T, Xia N
Microorganisms. 2023; 11(3).
PMID: 36985163
PMC: 10056367.
DOI: 10.3390/microorganisms11030589.
Liao Y, Bajwa K, Reddy S, Lupiani B
Microorganisms. 2021; 9(6).
PMID: 34200544
PMC: 8228275.
DOI: 10.3390/microorganisms9061260.
Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.
Teng M, Yao Y, Nair V, Luo J
Viruses. 2021; 13(5).
PMID: 33924851
PMC: 8146441.
DOI: 10.3390/v13050779.
"Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
Dogrammatzis C, Waisner H, Kalamvoki M
Viruses. 2020; 13(1).
PMID: 33374862
PMC: 7824580.
DOI: 10.3390/v13010017.
A Herpesviral Immediate Early Protein Promotes Transcription Elongation of Viral Transcripts.
Fox H, Dembowski J, DeLuca N
mBio. 2017; 8(3).
PMID: 28611249
PMC: 5472187.
DOI: 10.1128/mBio.00745-17.
Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability.
Ventosa M, Ortiz-Temprano A, Khalique H, Lim F
Gene Ther. 2017; 24(7):433-440.
PMID: 28553928
DOI: 10.1038/gt.2017.43.
Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
Lin C, Li H, Hao M, Xiong D, Luo Y, Huang C
Sci Rep. 2016; 6:34531.
PMID: 27713537
PMC: 5054376.
DOI: 10.1038/srep34531.
Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.
Kato A, Ando T, Oda S, Watanabe M, Koyanagi N, Arii J
J Virol. 2016; 90(12):5622-5635.
PMID: 27030266
PMC: 4886770.
DOI: 10.1128/JVI.00446-16.
Engineering large viral DNA genomes using the CRISPR-Cas9 system.
Suenaga T, Kohyama M, Hirayasu K, Arase H
Microbiol Immunol. 2014; 58(9):513-22.
PMID: 25040500
PMC: 7168497.
DOI: 10.1111/1348-0421.12180.
Herpes simplex virus 1 ICP22 but not US 1.5 is required for efficient acute replication in mice and VICE domain formation.
Mostafa H, Davido D
J Virol. 2013; 87(24):13510-9.
PMID: 24089574
PMC: 3838291.
DOI: 10.1128/JVI.02424-13.
Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastases.
Cody J, Scaturro P, Cantor A, Gillespie G, Parker J, Markert J
Int J Breast Cancer. 2013; 2012:628697.
PMID: 23346408
PMC: 3549352.
DOI: 10.1155/2012/628697.
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.
Markert J, Cody J, Parker J, Coleman J, Price K, Kern E
J Virol. 2012; 86(9):5304-13.
PMID: 22379082
PMC: 3347348.
DOI: 10.1128/JVI.06998-11.
A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei.
Bowles R, Blaho J
J Neurovirol. 2011; 17(6):559-69.
PMID: 22139604
DOI: 10.1007/s13365-011-0064-z.
The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.
Charvat R, Breitenbach J, Ahn B, Zhang Y, OCallaghan D
Virology. 2011; 412(2):366-77.
PMID: 21324502
PMC: 3060994.
DOI: 10.1016/j.virol.2011.01.025.
Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents.
Parker J, Zheng X, Luckett W, Markert J, Cassady K
Mol Pharm. 2010; 8(1):44-9.
PMID: 21142023
PMC: 3034828.
DOI: 10.1021/mp100230y.
Ultrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo.
Mehta H, Muller J, Markovitz N
J Virol. 2010; 84(21):10982-90.
PMID: 20702618
PMC: 2953204.
DOI: 10.1128/JVI.00337-10.
Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
Halder S, Murakami M, Verma S, Kumar P, Yi F, Robertson E
PLoS One. 2009; 4(9):e7214.
PMID: 19784370
PMC: 2746279.
DOI: 10.1371/journal.pone.0007214.